DD263990A5 - Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptan-substituierten aethern und thioaethern - Google Patents

Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptan-substituierten aethern und thioaethern Download PDF

Info

Publication number
DD263990A5
DD263990A5 DD87305257A DD30525787A DD263990A5 DD 263990 A5 DD263990 A5 DD 263990A5 DD 87305257 A DD87305257 A DD 87305257A DD 30525787 A DD30525787 A DD 30525787A DD 263990 A5 DD263990 A5 DD 263990A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
acid
hept
title compound
oxabicyclo
Prior art date
Application number
DD87305257A
Other languages
German (de)
English (en)
Inventor
Ravi K Varma
Eric M Gordon
Ligaya M Simpkins
Original Assignee
�K@�K@������@�K@����k���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �K@�K@������@�K@����k���Kk�� filed Critical �K@�K@������@�K@����k���Kk��
Publication of DD263990A5 publication Critical patent/DD263990A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD87305257A 1986-07-23 1987-07-22 Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptan-substituierten aethern und thioaethern DD263990A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (1)

Publication Number Publication Date
DD263990A5 true DD263990A5 (de) 1989-01-18

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87305257A DD263990A5 (de) 1986-07-23 1987-07-22 Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptan-substituierten aethern und thioaethern

Country Status (29)

Country Link
US (1) US4673685A (nl)
JP (1) JP2557894B2 (nl)
KR (1) KR950010596B1 (nl)
AT (1) AT397094B (nl)
AU (1) AU599384B2 (nl)
BE (1) BE1000141A3 (nl)
CA (1) CA1292003C (nl)
CH (1) CH674010A5 (nl)
DD (1) DD263990A5 (nl)
DE (1) DE3724152A1 (nl)
DK (1) DK383587A (nl)
ES (1) ES2006784A6 (nl)
FI (1) FI873207A (nl)
FR (1) FR2601953B1 (nl)
GB (1) GB2192882B (nl)
GR (1) GR871147B (nl)
HU (1) HU198495B (nl)
IE (1) IE60487B1 (nl)
IL (1) IL82919A0 (nl)
IT (1) IT1222054B (nl)
LU (1) LU86949A1 (nl)
NL (1) NL8701742A (nl)
NO (1) NO168359C (nl)
NZ (1) NZ220677A (nl)
PH (1) PH23711A (nl)
PT (1) PT85381B (nl)
SE (1) SE8702936L (nl)
YU (1) YU46321B (nl)
ZA (1) ZA874255B (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4368332A (en) * 1979-01-05 1983-01-11 National Research Development Corporation Prostaglandins
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4628061A (en) * 1981-12-23 1986-12-09 National Research Development Corporation Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
GR871147B (en) 1987-12-04
GB2192882B (en) 1990-05-09
PT85381A (en) 1987-08-01
BE1000141A3 (fr) 1988-05-03
HUT47115A (en) 1989-01-30
ES2006784A6 (es) 1989-05-16
US4673685A (en) 1987-06-16
DK383587A (da) 1988-01-24
JP2557894B2 (ja) 1996-11-27
FI873207A (fi) 1988-01-24
DK383587D0 (da) 1987-07-22
ZA874255B (en) 1988-02-24
AU599384B2 (en) 1990-07-19
FR2601953A1 (fr) 1988-01-29
SE8702936D0 (sv) 1987-07-22
NO873069D0 (no) 1987-07-22
HU198495B (en) 1989-10-30
DE3724152A1 (de) 1988-02-04
AU7444887A (en) 1988-01-28
CA1292003C (en) 1991-11-12
IT1222054B (it) 1990-08-31
NL8701742A (nl) 1988-02-16
IE871675L (en) 1988-01-23
FR2601953B1 (fr) 1990-11-16
LU86949A1 (fr) 1988-02-02
NZ220677A (en) 1989-12-21
CH674010A5 (nl) 1990-04-30
NO873069L (no) 1988-01-25
KR880001660A (ko) 1988-04-25
YU138187A (en) 1988-12-31
FI873207A0 (fi) 1987-07-21
YU46321B (sh) 1993-05-28
NO168359C (no) 1992-02-12
PH23711A (en) 1989-09-27
PT85381B (pt) 1990-04-30
JPS6335576A (ja) 1988-02-16
SE8702936L (sv) 1988-04-07
IL82919A0 (en) 1987-12-20
IE60487B1 (en) 1994-07-27
ATA174887A (de) 1993-06-15
NO168359B (no) 1991-11-04
AT397094B (de) 1994-01-25
GB8714621D0 (en) 1987-07-29
GB2192882A (en) 1988-01-27
IT8721328A0 (it) 1987-07-16
KR950010596B1 (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
DE2923815C2 (nl)
DE3851769T2 (de) Substituierte Benzazepine, ihre Herstellung und sie enthaltende Arzneimittel.
DE3851114T2 (de) Trizyklische Verbindungen.
EP0228045B1 (de) Aromatische Thioether
DD235259A5 (de) Verfahren zur herstellung von 5,11-dihydro-11-[[(1-methyl-4-piperidinyl)amino]carbonyl]-6 h-dibenz[b,e]azepin-6-on und dessen salzen
DE69110713T2 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE3346047A1 (de) 7-oxabicycloheptansubstituierte aminoprostaglandin-analoge
DD263990A5 (de) Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptan-substituierten aethern und thioaethern
EP0335315B1 (de) Neue Alkanophenone
DE3441660A1 (de) 7-oxabicycloheptanthioaether und arzneimittel mit einem gehalt an diesen verbindungen
DE69217613T2 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3806549A1 (de) 7-oxabicycloheptan-substituierte aminoprostaglandin-analoge
EP0085899B1 (de) Neue Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3621560A1 (de) 5,6-epoxy-7-oxabicycloheptan-substituierte aether und diese enthaltende arzneimittel
DE3409124A1 (de) 7-oxabicycloheptan-substituierte prostaglandin-analoge
DE3735128A1 (de) 7-oxabicycloheptan-derivate und diese verbindungen enthaltende arzneimittel
DE3784772T2 (de) Verfahren zur herstellung von 7-oxabicycloheptan-aminoalkohol-zwischenprodukten zur verwendung in der herstellung von thromboxan-a2-antagonisten und zwischenprodukte in diesem verfahren.
DE3621449A1 (de) 5,6-epoxy-7-oxabicycloheptansubstituierte aminoprostaglandin-analoga und diese enthaltende arzneimittel
DE3871705T2 (de) 2,4-disubstituierte tetrahydrofuranderivate.
DE3515208A1 (de) 7-oxabicycloheptan-substituierte oxaprostaglandin-analoge
DE3715208A1 (de) 7-oxabicycloheptan-substituierte amido-carbamoyl-prostaglandin-analoge
DE3502512A1 (de) 7-oxabicycloheptan-substituierte oxaprostaglandin-analoge
DE3601841A1 (de) 7-oxabicycloheptan-derivate
EP0226871A1 (de) Ausgangsprodukte zur Herstellung von 9-beta-Chlorprostaglandinen
EP0419410A2 (de) Weitere neue Alkanophenone

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee